Mechanisms of triple-negative breast cancer progression, metastasis and drug resistance, also working on the role of cancer induced hypercalcemia in triple-negative breast cancer progression and drug
I'm looking for
7 months ago
Alternative funding and/or partnerships to drive research on molecular targets identified from our work
About
I hold a PhD in Medical Biochemistry from Uppsala University and a Master of Science in Clinical Investigation from Meharry medical College. I have broad expertise in biochemistry, molecular parasitology and molecular and cellular biology, cancer biology and cellular signaling including calcium signaling in cancer. My laboratory at Meharry studies mechanisms underlying the aggressiveness and drug resistance of triple-negative breast cancer (TNBC), and interested in research on molecular target driven cancer drug resistance, extracellular vesicles in cancer progression and drug resistance and mechanisms of invasive/aggressive cancer progression.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Abstract P1-07-26: Annexin A6 modulates the secretion of pro-inflammatory cytokines and exosomes via membrane fusion with SNAP 23 in triple negative breast cancer
Clinical Cancer Research
•
2025
Abstract P2-04-13: DIFFERENTIAL SUSCEPTIBILITY OFMESENCHYMAL-LIKE AND BASAL-LIKE TRIPLE NEGATIVE BREAST CANCER CELLS TO STANDARD OF CARE TREATMENT
Clinical Cancer Research
•
2025
Implementation of an Integrated Active Learning PhD Curriculum in Biomedical Science
The A986S calcium sensing receptor variant supports the adaptation of breast cancer cells to high calcium — a novel paradigm in breast cancer progression
Abstract LB127: Reduced expression of annexin-a6 induces metabolic reprogramming that favors rapid fatty acid oxidation in triple-negative breast cancer cells
Cancer Research
•
2022
The Role of Annexin A6 in Triple‐negative breast cancer metabolism and disease progression